IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance
BackgroundMyocardial ischemia/reperfusion injury (MIRI) is a critical problem in cardiovascular medicine, often occurring after coronary revascularization procedures or cardiopulmonary bypass. The characters of MIRI are both energy metabolism disturbances and severe myocardium insulin resistance (IR...
Saved in:
| Main Authors: | Jue Bai, Si-Yuan Yang, Shao-Mei Yu, Ying Cao, Chang-Han Ma, Xuan-Yi Hu, Xiong Chen, Ying-Nan Song, Hong-Jin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1544869/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANTIBACTERIAL AND IMMUNOTROPIC PROPERTIES OF ISOLIQUIRITIGENIN IN GENERALIZED STAPHYLOCOCCAL INFECTION IN MICE
by: E. A. Solyonova, et al.
Published: (2020-12-01) -
Isoliquiritigenin Alleviates Periodontitis by Suppressing Inflammation via NF-κB Signaling Pathway of Immune Cell
by: Wang X, et al.
Published: (2025-05-01) -
Isoliquiritigenin Promotes the Repair of High Uric Acid‐Induced Vascular Injuries
by: Hongyan Zhou, et al.
Published: (2025-06-01) -
IGFBP2 and IGFBP4 interact to activate complement pathway in diabetic kidney disease
by: Jieling Liang, et al.
Published: (2025-12-01) -
Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
by: Waimao Gao, et al.
Published: (2025-02-01)